• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Compass Therapeutics, Inc. - Common Stock (NQ:CMPX)

5.475 +0.565 (+11.51%)
Streaming Delayed Price Updated: 10:09 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 644,640
Open 4.925
Bid (Size) 5.470 (200)
Ask (Size) 5.480 (600)
Prev. Close 4.910
Today's Range 4.925 - 5.570
52wk Range 1.330 - 5.860
Shares Outstanding 127,486,326
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Compass Therapeutics Inc (NASDAQ:CMPX) Reports Wider Q2 2025 Loss, Shares Show Mixed Reaction Amid Clinical Progress ↗
August 11, 2025
Compass Therapeutics reports Q2 2025 results with a wider-than-expected loss but shows progress in clinical trials for oncology treatments. Market reacts mixedly. 
Via Chartmill
News headline image
Compass Therapeutics Posts Wider Q2 Loss ↗
August 11, 2025
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+5.9%
+5.9%
1 Month
+2.1%
+2.1%
3 Month
+51.7%
+51.7%
6 Month
+106.6%
+106.6%
1 Year
+246.5%
+246.5%

More News

Read More
News headline image
Top movers in Wednesday's session ↗
April 02, 2025
Via Chartmill
News headline image
Small Cap Compass Therapeutics Shares Positive Primary Goal Data From Pivotal Cancer Drug Study For Biliary Tract Cancer ↗
April 01, 2025
Via Benzinga
News headline image
Recap: Compass Therapeutics Q3 Earnings ↗
November 09, 2023
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2025 ↗
August 11, 2025
Via Benzinga
News headline image
What's going on in today's after hours session ↗
March 31, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
March 31, 2025
Via Benzinga
News headline image
This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
February 24, 2025
Via Benzinga
News headline image
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
February 19, 2025
Via Benzinga
News headline image
Top 3 High-Momentum Companies Analysts Are Still Bullish On
February 04, 2025
Via MarketBeat
News headline image
CMPX Stock Earnings: Compass Therapeutics Meets EPS for Q2 2024 ↗
August 12, 2024
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
June 10, 2024
Via Benzinga
News headline image
CMPX Stock Earnings: Compass Therapeutics Beats EPS for Q1 2024 ↗
May 13, 2024
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
May 01, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
April 26, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
April 25, 2024
Via Benzinga
News headline image
3 Penny Stocks With the Power to 10X Your $1K Investment ↗
March 24, 2024
Via InvestorPlace
News headline image
CMPX Stock Earnings: Compass Therapeutics Misses EPS for Q4 2023 ↗
March 21, 2024
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
March 13, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
March 05, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
February 27, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
January 17, 2024
Via Benzinga
News headline image
3 Healthcare Stocks To Make You The Millionaire Next Door: October Edition ↗
October 13, 2023
Via InvestorPlace
News headline image
Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
September 05, 2023
Via Benzinga

Frequently Asked Questions

Is Compass Therapeutics, Inc. - Common Stock publicly traded?
Yes, Compass Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Compass Therapeutics, Inc. - Common Stock trade on?
Compass Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Compass Therapeutics, Inc. - Common Stock?
The ticker symbol for Compass Therapeutics, Inc. - Common Stock is CMPX on the Nasdaq Stock Market
What is the current price of Compass Therapeutics, Inc. - Common Stock?
The current price of Compass Therapeutics, Inc. - Common Stock is 5.475
When was Compass Therapeutics, Inc. - Common Stock last traded?
The last trade of Compass Therapeutics, Inc. - Common Stock was at 01/07/26 10:09 AM ET
What is the market capitalization of Compass Therapeutics, Inc. - Common Stock?
The market capitalization of Compass Therapeutics, Inc. - Common Stock is 697.99M
How many shares of Compass Therapeutics, Inc. - Common Stock are outstanding?
Compass Therapeutics, Inc. - Common Stock has 698M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap